Podcast:The Long Run with Luke Timmerman Published On: Fri Jan 20 2023 Description: Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.